drugset / Trial / NCT00717379

Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

NCT00717379

Phase 4 Completed 50 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the efficacy and safety of Tacrolimus in combination with MMF and Steroids in two regimens of steroid in an adult kidney transplanted population.

Timeline

Start
2007-05
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule Oral
Background Methylprednisolone Other / unclassified Oral
Background Mycophenolate Mofetil Small molecule Oral
Background Prednisone Other / unclassified Oral